Oncotarget

Research Papers:

This article has been corrected. Correction in: Oncotarget. 2021; 12:1859-1860.

MicroRNA-126 inhibits tumor proliferation and angiogenesis of hepatocellular carcinoma by down-regulating EGFL7 expression

Ming-Hua Hu, Chen-Yang Ma, Xiao-Ming Wang, Chen-Dong Ye, Guang-Xian Zhang, Lin Chen and Jin-Guo Wang _

PDF  |  HTML  |  How to cite  |  Order a Reprint

Oncotarget. 2016; 7:66922-66934. https://doi.org/10.18632/oncotarget.11877

Metrics: PDF 1832 views  |   HTML 1976 views  |   ?  


Abstract

Ming-Hua Hu1, Chen-Yang Ma1, Xiao-Ming Wang1, Chen-Dong Ye2, Guang-Xian Zhang1, Lin Chen1, Jin-Guo Wang1

1Department of Surgery, Yijishan Hospital, Wannan Medical College, Wuhu 241001, P.R. China

2Department of Surgery, The Second Affiliated Hospital, Wannan Medical College, Wuhu 241001, P.R. China

Correspondence to:

Jin-Guo Wang, email: kikiki_ab@163.com

Keywords: MicroRNA-126, EGFL7, hepatocellular carcinoma, proliferation, angiogenesis

Received: April 20, 2016     Accepted: August 12, 2016     Published: September 06, 2016

ABSTRACT

This study aims to explore the effects of microRNA-126 (miR-126) on tumor proliferation and angiogenesis of hepatocellular carcinoma (HCC) by targeting EGFL7. HCC tissues and adjacent normal tissues were obtained from 71 HCC patients. Immunohistochemistry (IHC) was conducted to detect expressions of EGFL7 and VEGF and the micro-vessel density (MVD). HCC cell lines were collected and assigned into the blank, miR-126 mimics, miR-126 inhibitors, miR-126 mimics negative control (NC), miR-126 inhibitors NC, si-EGFL7, and miR-126 inhibitors + si-EGFL7 groups. Expressions of miR-126 and EGFL7 mRNA were detected by qRT-PCR assay. The protein expressions of EGFL7 and VEGF were measured by Western blotting. MTT assay was used to measure the proliferation of HCC cells. Tumor xenograft model in nude mice was utilized to evaluate the influence of miR-126 on tumor growth. HCC tissues had higher miR-126 expression and lower EGFL7 mRNA expression than adjacent normal tissues. Compared with the blank, miR-126 mimic NC, miR-126 inhibitor NC and miR-126 inhibitors + si-EGFL7 groups, the protein expressions of EGFL7 and VEGF and cell proliferation were reduced in the miR-126 mimics and si-EGFL7 groups, while the opposite trend was found in the miR-126 inhibitors group. Compared with the blank and miR-126 inhibitors + siRNA-EGFL7 groups, tumor size, tumor weight, and MVD of transplanted tumors in nude mice were significantly reduced in the miR-126 mimics and siRNA-EGFL7 groups, while the opposite trend was found in the miR-126 inhibitors group. In conclusion, miR-126 could inhibit tumor proliferation and angiogenesis of HCC by down-regulating EGFL7 expression.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 11877